linking immunotherapy to better outcomes in resectable melanoma
Published 2 years ago • 339 plays • Length 54:59Download video MP4
Download video MP3
Similar videos
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
1:05:54
melanoma care: continued progress with immunotherapy in resectable and unresectable disease
-
1:09:01
resectable melanoma: perspectives on using immune-based adjuvant and neoadjuvant therapy
-
1:26:11
immunotherapy for the win against melanoma
-
1:20:31
choosing innovation with immunotherapy in melanoma
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
2:29:14
from innovation to impact: advancing melanoma treatment at sarah cannon research institute
-
1:23:36
collaborative care and next steps with adjuvant and neoadjuvant immunotherapy for melanoma
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
0:40
gamma signature guidance in optimizing neoadjuvant immunotherapy for resectable melanoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
1:07:38
drs. wargo, ariyan, & postow discuss #melanoma at #sso2023 - https://bit.ly/40kl2pl
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
1:57:09
new concepts in immunotherapy for solid tumors